Apr 15 2020;411:116715
This information alone does not predict your exact response, but may help provide context for your provider when discussing dose escalation strategy
[DOI] [PMC free article] [PubMed] [Google Scholar] 270.Romani-Perez M., Outeirino-Iglesias V., Moya C.M., Santisteban P., Gonzalez-Matias L.C., Vigo E., Mallo F
High-quality human clinical trials are lacking, and optimal dosing, long-term safety, and efficacy have not been established, meaning its use for IBS and Crohns should be considered investigational rather than a standard therapeutic option
177 ZimeringJ
a-c , Dynamics of HyPerFLEX response in HeLa cells to varying external H 2 O 2 concentrations using fluorogens HBR-3,5-DOM ( a ), N871b ( b ), and 3a ( c )